Regional cyclin D1 overexpression or hypoxia correlate inversely with heterogeneous oestrogen receptor-α expression in human breast cancer

In Vivo

Volumn 17, Issue 4, 2003, Pages 311-318

  Kronblad, Åsa ^a   Helczynska, Karolina ^a   Nielsen, Niels Hilmer ^b   Påhlman, Emdin ^b   Emdin, Stefan ^b   Påhlman, Sven ^a   Landberg, Göran ^a  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Cyclin D1; ER ; Hypoxia; Proliferation

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HYPOXIA; WESTERN BLOTTING;

EID: 0043124314     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Dorssers LC, Van Den Flier S, Brinkman A et al: Tamoxifen resistance in breast cancer: Elucidating mechanisms. Drugs 61: 1721-1733, 2001.
2. Sherr CJ: Cancer cell cycles: Science 274: 1672-1677, 1996.
3. Nielsen NH, Lodén M, Cajander J, Emdin SO and Landberg G: G1-S transition defects occur in most breast cancers and predict outcome. Breast Cancer Res Treat 56: 105-112, 1999.
4. Hatakeyama M and Weinberg RA: The role of RB in cell cycle control. Prog Cell Cycle Res 1: 9-19, 1995.
5. Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N and Slingerland JM: Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Proc Natl Acad Sci USA 97: 9042-9046, 2000.
6. Carroll JS, Swarbrick A, Musgrove EA and Sutherland RL: Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: Implications for the antiproliferative effects of antiestrogens. Cancer Res 62: 3126-3131, 2002.
7. Lamb J, Ladha MH, McMahon C, Sutherland RL and Ewen ME: Regulation of the functional interaction between cyclin D1 and the ER. Mol Cell Biol 20: 8667-8675, 2000.
8. Zwijsen RML, Buckle RS, Hijams EM, Loomans CJM and Bernards R: Ligand-independent recruitment of steroid receptor coactivators to ER by cyclin D1. Genes Dev 12: 3488-3498, 1998.
9. Castro-Rivera E, Samudio I and Safe S: Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J Biol Chem 276: 30853-30861, 2001.
10. Zwijsen RML, Wientgens E, Klompmaker R, Van Der Sman J, Bernards R and Michalides RJAM: CDK-independent activation of ER by cyclin D1. Cell 88: 405-415, 1997.
11. Neuman E, Ladha MH, Lin N et al: Cyclin D1 stimulation of ER transcriptional activity independent of cdk4. Mol Cell Biol 17: 5338-5374, 1997.
12. Planas-Silva MD, Shang Y, Donaher JL, Brown M and Weinberg RA: AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res 61: 3858-3862, 2001.
13. Nielsen NH, Emdin SO, Cajander J and Landberg G: Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 14: 295-304, 1997.
14. Bindels E, Lallemand F, Balkenende E, Verwoerd D and Michalides R: Involvement of G1/S cyclins in estrogen independent proliferation of oestrogen receptor-positive breast cancer cells. Oncogene 21: 8158-8165, 2002.
15. Hui R, Finney G, Carroll J, Lee C, Musgrove E and Sutherland R: Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T47D breast cancer cells. Cancer Res 62: 6916-6923, 2002.
16. Bos R, Van Der Groep, Greijer A et al: Levels of HIF-1a independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97: 1573-1581, 2003.
17. Nielsen NH, Arnerlöv C, Emdin SO and Landberg G: Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to ER status. Br J Cancer 74: 874-880, 1996.
18. Lodén M, Stighall M, Nielsen NH et al: The cyclin D1 high and cyclin E high subgroups of breast cancer: Separate pathways in tumorigenesis based on pattern of genetic aberrations and inactivation of the pRb node. Oncogene 21: 4680-4690, 2002.
19. Kononen J, Bubendorf L, Kallioniemi A et al: Tissue microarrays for high-throughput molecular profiling of tumour specimens. Nat Med 7: 844-847, 1998.
20. Bos R, Zhong H, Hanrahan CF et al: Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 93: 309-314, 2001.
21. Elston CW and Ellis IO: Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology, 19: 403-410, 1991.
22. Johnston SR, Saccani-Jotti G, Smith IE et al: Changes in oestrogen receptor, progesterone receptor and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res 55: 3331-8, 1995.
23. Oyama T, Kashiwabara K, Yoshimoto K, Arnold A and Koerner F: Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res 58: 2876-2880, 1998.
24. Pacilio C, Germano D, Addeo R et al: Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens. Cancer Res 58: 871-876, 1998.
25. Lung JC, Chu JS, Yu JC et al: Aberrant expression of cell-cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability. Genes Chromosomes 34: 276-284, 2002.
26. Kurebayashi J, Otsuki T, Moriya T and Sonoo H: Hypoxia reduces hormone responsiveness of human breast cancer cells. Jpn J Cancer Res 92: 1093-1101, 2001.
27. Stoner M, Saville B, Wormke M, Dean D, Burghardt R and Safe S: Hypoxia induces proteosome dependent degradation of estrogen receptor alpha in Zr-75 breast cancer cells. Molecular Endo 16: 2231-2242, 2002.
28. Semenza GL: HIF-1 and tumour progression: pathophysiology and therapeutics. Trends Mol 8: 62-67, 2002.
29. Chia SK, Wykoff CC, Watson PH et al: Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19: 3660-3668, 2001.
30. Schindl M, Schoppmann F, Samonigg H et al: Overexpression of HIF-1alpha is associated with an unfavourable prognosis in lymph node positive breast cancer. Clin Cancer Res 8: 1831-1837, 2002.
31. Ström A, Arai N, Leers J and Gustafsson JA: The Hairy and Enhancer of Split homologue-1 (HES-1) mediates the proliferative effect of 17beta-estradiol on breast cancer cell lines. Oncogene 19: 5951-5953, 2000.
32. Jögi A, Öra I, Nilsson H et al: Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 99: 7021-7026, 2002.